Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Advanced Thyroid Carcinoma
NCT01118065Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- May 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in thyroid carcinoma (TC), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
everolimus
03
Conditions
thyroid carcinoma (TC)
Beyond the preview
Go deeper on NCT01118065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118065.